3-14178568-T-C
Variant summary
Our verdict is Uncertain significance. Variant got 4 ACMG points: 4P and 0B. PVS1_SupportingPM2PP5
The NM_004628.5(XPC):āc.1A>Gā(p.Met1?) variant causes a start lost change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0000242 in 1,612,532 control chromosomes in the GnomAD database, including 1 homozygotes. In-silico tool predicts a pathogenic outcome for this variant. Variant has been reported in ClinVar as Conflicting classifications of pathogenicity (no stars).
Frequency
Consequence
NM_004628.5 start_lost
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Uncertain_significance. Variant got 4 ACMG points.
Transcripts
RefSeq
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
XPC | ENST00000285021.12 | c.1A>G | p.Met1? | start_lost | Exon 1 of 16 | 1 | NM_004628.5 | ENSP00000285021.8 | ||
XPC | ENST00000476581.6 | n.1A>G | non_coding_transcript_exon_variant | Exon 1 of 15 | 1 | ENSP00000424548.1 | ||||
XPC | ENST00000511155.1 | c.1A>G | p.Met1? | start_lost | Exon 1 of 4 | 4 | ENSP00000423867.1 | |||
LSM3 | ENST00000306024.4 | c.-293T>C | upstream_gene_variant | 1 | NM_014463.3 | ENSP00000302160.3 |
Frequencies
GnomAD3 genomes AF: 0.0000131 AC: 2AN: 152244Hom.: 0 Cov.: 33
GnomAD3 exomes AF: 0.0000525 AC: 13AN: 247852Hom.: 0 AF XY: 0.0000593 AC XY: 8AN XY: 134850
GnomAD4 exome AF: 0.0000253 AC: 37AN: 1460288Hom.: 1 Cov.: 32 AF XY: 0.0000248 AC XY: 18AN XY: 726516
GnomAD4 genome AF: 0.0000131 AC: 2AN: 152244Hom.: 0 Cov.: 33 AF XY: 0.0000134 AC XY: 1AN XY: 74374
ClinVar
Submissions by phenotype
Xeroderma pigmentosum, group C Pathogenic:2Uncertain:1
- -
- -
This variant was observed in the ICSL laboratory as part of a predisposition screen in an ostensibly healthy population. It had not been previously curated by ICSL or reported in the Human Gene Mutation Database (HGMD: prior to June 1st, 2018), and was therefore a candidate for classification through an automated scoring system. Utilizing variant allele frequency, disease prevalence and penetrance estimates, and inheritance mode, an automated score was calculated to assess if this variant is too frequent to cause the disease. Based on the score, this variant could not be ruled out of causing disease and therefore its association with disease required further investigation. A literature search was performed for the gene, cDNA change, and amino acid change (if applicable). No publications were found based on this search. This variant was therefore classified as a variant of unknown significance for this disease. -
Xeroderma pigmentosum Pathogenic:1
Variant summary: XPC c.1A>G (p.Met1Val) alters the initiation codon and is predicted to result either in absence of the protein or truncation of the encoded protein due to translation initiation at a downstream codon. An alternative downstream in-frame start codon (Met118) is located in the encoded protein. An activation of potential downstream translation at this initiation site would result in a shortened protein missing the first 117 amino acids from the protein sequence. Two of four in-silico tools predict a damaging effect of the variant on protein function. The variant allele was found at a frequency of 5.2e-05 in 247852 control chromosomes (gnomAD). This frequency is not significantly higher than expected for a pathogenic variant in XPC causing Xeroderma Pigmentosum (5.2e-05 vs 0.00071), allowing no conclusion about variant significance. To our knowledge, no occurrence of c.1A>G in individuals affected with Xeroderma Pigmentosum and no experimental evidence demonstrating its impact on protein function have been reported. However, another variant affecting the ATG initiation codon of XPC, c.2T>G (p.Met1Arg), has been reported in individuals affected with Xeroderma Pigmentosa (Khan_2009). This change has also been shown to severely impair protein expression (Khan_2009), suggesting that variants affecting the start codon of XPC are likely to impact function. Three clinical diagnostic laboratories have submitted clinical-significance assessments for this variant to ClinVar after 2014 and classified the variant as either likely pathogenic (n=2) or VUS (n=1). Based on the evidence outlined above, the variant was classified as likely pathogenic. -
not provided Pathogenic:1
This sequence change affects the initiator methionine of the XPC mRNA. The next in-frame methionine is located at codon 118. This variant is present in population databases (rs763678756, gnomAD 0.02%). Disruption of the initiator codon has been observed in individual(s) with xeroderma pigmentosum (PMID: 18955168). ClinVar contains an entry for this variant (Variation ID: 551388). Studies have shown that disruption of the initiator codon alters XPC gene expression (PMID: 18955168). For these reasons, this variant has been classified as Pathogenic. -
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at